Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemens-Martin Wendtner

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Oncology and Therapy|May 14, 2026
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic LeukemiaPaolo Ghia, Jennifer R Brown, Mazyar Shadman, et al.
Leukemia & Lymphoma|September 16, 2014
Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemiaValentin Goede, Barbara Eichhorst, Kirsten Fischer, et al.
Experimental Hematology|June 27, 2006
Human Ly9 (CD229) as novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (B-CLL) recognized by autologous CD8+ T cellsDagmar Bund, Christine Mayr, David M Kofler, et al.
Experimental Hematology|May 30, 2007
CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytesDagmar Bund, Christine Mayr, David M Kofler, et al.
Blood|August 19, 2016
Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cellsElena Faitschuk, Andreas A Hombach, Lukas P Frenzel, et al.
Blood|July 15, 2005
Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cellsChristine Mayr, David M Kofler, Hildegard Büning, et al.
Deutsche Medizinische Wochenschrift (1946)|March 13, 2024
[Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany]Dennis Häckl, Marc Pignot, Phi Long Dang, et al.
Leukemia Research|October 8, 2008
Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockadeChristian P Pallasch, Sabine Ulbrich, Reinhild Brinker, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 15, 2014
Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNAVictor Max Corman, Stephan Ölschläger, Clemens-Martin Wendtner, et al.
Leukemia & Lymphoma|October 14, 2011
The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literatureStéphane Lepretre, Uli Jäger, Ann Janssens, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Oncology and Therapy|May 14, 2026
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic LeukemiaPaolo Ghia, Jennifer R Brown, Mazyar Shadman, et al.
Leukemia & Lymphoma|September 16, 2014
Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemiaValentin Goede, Barbara Eichhorst, Kirsten Fischer, et al.
Experimental Hematology|June 27, 2006
Human Ly9 (CD229) as novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (B-CLL) recognized by autologous CD8+ T cellsDagmar Bund, Christine Mayr, David M Kofler, et al.
Experimental Hematology|May 30, 2007
CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytesDagmar Bund, Christine Mayr, David M Kofler, et al.
Blood|August 19, 2016
Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cellsElena Faitschuk, Andreas A Hombach, Lukas P Frenzel, et al.
Blood|July 15, 2005
Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cellsChristine Mayr, David M Kofler, Hildegard Büning, et al.
Deutsche Medizinische Wochenschrift (1946)|March 13, 2024
[Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany]Dennis Häckl, Marc Pignot, Phi Long Dang, et al.
Leukemia Research|October 8, 2008
Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockadeChristian P Pallasch, Sabine Ulbrich, Reinhild Brinker, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 15, 2014
Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNAVictor Max Corman, Stephan Ölschläger, Clemens-Martin Wendtner, et al.
Leukemia & Lymphoma|October 14, 2011
The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literatureStéphane Lepretre, Uli Jäger, Ann Janssens, et al.
Pageof 11